SAIC Capital is a corporate venture capital firm established in 2014 to invest in early and growth stage technology companies for the transportation industry.
The round was led by Deepbridge Capital to help manufacture trial units for a new urinary tract infection diagnostic device.
"FluoretiQ perfectly represents the type of highly innovative and growth-focused companies Deepbridge Capital is committed to supporting within the sector-specific Deepbridge Life Sciences EIS fund; a great example of the importance of the Enterprise Investment Scheme. Neciah has built a great team, eager to take on the significant challenge this market demands, and we are pleased to be working with them on this next exciting stage of their journey."
— Savvas Neophytou, Partner & Head of Life Sciences
The funding round was led by Tarsadia Investments with participation from automotive leaders including Hyundai Mobis, General Motors Ventures, SAIC Capital, and Van Tuyl Companies.
"Enhanced in-car experience is the next automotive revolution that goes hand in hand with electrification and the development of autonomous vehicles. Our technology is class leading and is extremely well placed to meet current and future requirements."
